CORR
U nicompartmental knee arthroplasty (UKA) increases the risk of revision compared to TKA in the mid-to long-term [2] . Although UKAs account for only a small proportion of the arthroplasties performed globally, orthopaedic surgeons, at least in tertiary referral centers, do see patients who opt for revision surgery to convert a UKA to a TKA.
Revising a UKA to a TKA is not comparable to performing a primary TKA, either in terms of functional outcome or implant survivorship [6] . In fact, a recent study [1] found that the overall risk of re-revision after a UKA to a TKA revision is similar to that of a TKA to a TKA revision. Therefore, it is important to find approaches that can improve upon these revisions, as revision procedures are hard both on the patient and the healthcare system. Although little is currently known about the factors that affect the risk for rerevision after such surgery, the present study by Lewis and colleagues [5] , using a large register-based study sample, provides us with some novel findings.
The authors of the current study performed a register-based analysis to assess the factors affecting implant survivorship after UKA revisions in Australia, where surgeons revised 4438 UKAs to a TKA due to aseptic failures from 2002 to 2015. The authors found that the risk of re-revision after a UKA revision was reduced when a stem extension (either alone or in combination with metallic augment) was used.
Lewis and colleagues found that the threshold to use a stem extension should be low (if any) when revising a UKA to a TKA. After all, a stem extension can be easily applied and does not markedly increase morbidity associated with the revision. Leta and colleagues [4] recently found that the most common reason for re-revision (after a UKA to a TKA revision) is tibial loosening; this finding also supports the policy to readily secure initial stability of the tibial component with a stem extension.
Where Do We Need To Go?
Although we should not hesitate to use stem extensions in these revisions, many important questions remain unanswered. First, if we decide to apply a tibial stem extension while performing a UKA to TKA revision, should we use a short cemented metaphyseal stem rather than a cementless diaphyseal engaging stem extension? Second, as instability is a common reason for re-revision after revision UKA, should we lower the threshold to use more-constrained TKA implants at the time of index UKA revision? And third, how large should a bony defect have to be in order to warrant the use of One could argue that these unanswered questions require more-detailed clinical and radiographic data than can be obtained from registers, and should thus, be tackled with the heaviest tool in the scientific kit-a randomized-controlled trial. Unfortunately, randomized controlled trials cannot realistically answer these questions. How can we be so sure? Here's an example: In the present study, the overall 10-year cumulative percent revision (CPR) for UKAs revised to TKAs was 16% (95% CI, 14.5-17.7). If future researchers study the implant or method that is expected to improve that CPR by five percentage points (that is, CPR of 11% or less at 10 years), one should randomize 1482 patients per study arm, totaling 2964 UKA to TKA revisions. These numbers cannot plausibly be reached with a randomized controlled trial, even if we included multiple centers. Therefore, we should once again turn to the modern arthroplasty registers and their longitudinally collected data. After all, the results of well-designed observational studies do not systematically overestimate the magnitude of the effects of treatment as compared with those randomized controlled trials [1] . Additionally, the Finnish Arthroplasty Register [3] now includes detailed information on all implants during surgery (based on barcode reading), meaning that detailed information on the type of stem extensions, augments, and degree of constrain is already available.
Understanding the severity of bone defects, is clearly more difficult to answer. One solution would be the implementation of bone-defect classifications into the registers-an arduous approach that is not realistic. Perhaps a more-practical approach would combine information from national registers and selected high-volume centers that routinely classify bone defects in knee revisions. By picking up a cohort of UKA revisions from an arthroplasty register, and obtaining more detailed clinical and radiographic data of these patients from the participating centers, one could assess the effect of bone defects as well other radiographic and clinical variables on the outcome of these revisions. To obtain sufficient power, the latter approach should most likely be implemented as a cross-border multicenter project. Indeed, the task is challenging and time-consuming, but it a feasible approach. It seems evident that when it comes to studying the outcome of UKA to TKA revisions, we have more hard work ahead of us.
